<DOC>
	<DOCNO>NCT02460250</DOCNO>
	<brief_summary>According French Biomedicine Agency annual report retrieval activity transplant , 1,164 liver transplant perform 2011 1,161 2012 . If amount brain death donor retrieve liver grafts appear relatively stable , remain clearly insufficient compare increase number patient wait list liver transplantation ( 2,462 2011 ) . The median time wait list liver transplantation establish cohort patient register 2007 2011 ( exclude patient register emergency transplantation live related-donor transplantation ) increase significantly 4.4 month 2007 2009 6.6 month 2010 2011 . In order compensate lack liver graft , donor acceptance criterion broaden . For example , alternative transplantation list create liver graft come so-called `` marginal '' donor . However , despite effort , liver retrieve two three brain death donor , i.e . 1,572 1,589 organ donor 2011 2012 , respectively . This unfortunately enough meet increase need liver graft grow number patient wait year transplant . Strategic line improvement define order meet `` 2012-2016 transplant perspective '' target 5,700 transplant carried 2015 ( +5 % every year , transplant include , 5,023 transplant 2012 ) . According last consensus conference liver transplantation HAS ( French High Authority Health ) assessment degree macrovacuolar microvacuolar steatosis determines possibility retrieve graft . Liver steatosis consist accumulation fatty droplet hepatocytes . Its prevalence high , range 16 % 31 % general population , increase 46 % heavy drinker 50-80 % obese population . Steatosis result mostly alcohol consumption metabolic syndrome ( obesity , type 2 diabetes , hypertriglyceridemia ) call non-alcoholic fatty liver disease ( NAFLD ) , rarely secondary viral hepatitis exposure certain medication . NAFLD involve 30 % population Western country prevalence increase . NAFLD may lead asymptomatic steatosis , also steatohepatitis advance fibrosis include cirrhosis complication Accordingly , improvement liver graft selection base objective quantitative criterion take account degree liver steatosis appear crucial increase number hepatic transplant .</brief_summary>
	<brief_title>Evaluation Liver Grafts With FibroScan® Before Organ Retrieval Patients With Brain Death</brief_title>
	<detailed_description>Medical procedure : Fibroscan® base vibration control transient elastography ( VCTETM ) evaluation control attenuation parameter ( CAP™ ) ultrasounds ( Echosens , Paris , France ) .</detailed_description>
	<mesh_term>Death</mesh_term>
	<mesh_term>Brain Death</mesh_term>
	<criteria>Patients older 18 year recognize clinical brain death confirm clinical examination , consider organ retrieval clinically stable achieve retrieval procedure Personal objection organ retrieval clinical research express lifetime register Registre National de Refus ( French registration refusal organ donation ) Family objection liver retrieval donor 's death Ongoing pregnancy brain death declare For FT ST measurement include panel FibroMaxTM , 4 exclusion criterion define specifically ( Acute hepatitis cytolysis ALT high 622 IU/L , acute chronic hemolysis , extrahepatic cholestasis , sepsis )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Tissue Organ Harvesting</keyword>
	<keyword>Liver graft</keyword>
	<keyword>Brain Death</keyword>
	<keyword>FibroScan®</keyword>
</DOC>